title: Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus.
abstract: OBJECTIVE
  Chronic hyperglycaemia increases dipeptidyl peptidase IV (DPP-IV) activity in endothelial cells in vitro. The present study was designed to assess the effect of high glucose on circulating DPP-IV activity in patients with type 1 and type 2 diabetes.
  
  
  METHODS
  Plasma DPP-IV activity was measured in 29 patients with type 1 diabetes and 29 age-, sex- and BMI-matched control subjects. We also assessed DPP-IV activity in 31 type 2 diabetic patients with HbA1c > 8.5% and in plasma from matched groups of 31 newly diagnosed diabetic subjects with HbA1c < 7.5%, 31 subjects with IGT and 62 subjects with NGT. In a further sample of 66 type 2 diabetic patients, a longitudinal study was also performed to evaluate variations in DPP-IV activity and HbA1c over 3 months.
  
  
  RESULTS
  DPP-IV activity in type 1 diabetic patients was not significantly different from that in control subjects; however, a significant correlation between DPP-IV and HbA1c was observed in diabetic subjects (r = 0.47; p < 0.01). Type 2 diabetic patients with HbA1c > 8.5% showed significantly (p < 0.05) higher DPP-IV activity (mean+/-SD 27.7+/-7.1 U/l) than newly diagnosed diabetic patients and subjects with IGT (22.1+/-6.0 and 18.8+/-8.8 U/l, respectively). Variations in DPP-IV activity over 3 months in type 2 diabetic patients showed a significant positive correlation with variations in HbA1c (r = 0.26; p < 0.05).
  
  
  CONCLUSIONS
  Chronic hyperglycaemia induces a significant increase in DPP-IV activity in type 1 and type 2 diabetes. This phenomenon could contribute to the reduction in circulating active glucagon-like peptide-1 and to the consequent postprandial hyperglycaemia in type 2 diabetic patients with poor metabolic control.
authors.affiliation: Diabetology, Geriatric Unit, Department of Critical Care, University of Florence, Florence, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Mannucci
authors.forename: L
authors.initials: L
authors.lastname: Pala
authors.forename: S
authors.initials: S
authors.lastname: Ciani
authors.forename: G
authors.initials: G
authors.lastname: Bardini
authors.forename: A
authors.initials: A
authors.lastname: Pezzatini
authors.forename: I
authors.initials: I
authors.lastname: Sposato
authors.forename: F
authors.initials: F
authors.lastname: Cremasco
authors.forename: A
authors.initials: A
authors.lastname: Ognibene
authors.forename: C M
authors.initials: CM
authors.lastname: Rotella
mesh_terms: D000328:Adult; D000368:Aged; D015992:Body Mass Index; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000201:enzymology*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000201:enzymology*; D018819:Dipeptidyl Peptidase 4 / Q000097:blood*; D005260:Female; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000378:metabolism*; D008137:Longitudinal Studies; D008297:Male; D012016:Reference Values; D012044:Regression Analysis
chemical_list: D018819:Dipeptidyl Peptidase 4